These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23784831)

  • 1. Testicular teratomas: an intersection of pluripotency, differentiation and cancer biology.
    Bustamante-Marín X; Garness JA; Capel B
    Int J Dev Biol; 2013; 57(2-4):201-10. PubMed ID: 23784831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
    An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
    Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in mice.
    Heaney JD; Anderson EL; Michelson MV; Zechel JL; Conrad PA; Page DC; Nadeau JH
    Development; 2012 May; 139(9):1577-86. PubMed ID: 22438569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.
    Krentz AD; Murphy MW; Kim S; Cook MS; Capel B; Zhu R; Matin A; Sarver AL; Parker KL; Griswold MD; Looijenga LH; Bardwell VJ; Zarkower D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22323-8. PubMed ID: 20007774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent cells in embryogenesis and in teratoma formation.
    Gordeeva OF
    J Stem Cells; 2011; 6(1):51-63. PubMed ID: 22997845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MC4R mutant mice develop ovarian teratomas.
    Naser AA; Miyazaki T; Wang J; Takabayashi S; Pachoensuk T; Tokumoto T
    Sci Rep; 2021 Feb; 11(1):3483. PubMed ID: 33568756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From stem cells to germ cell tumors and back.
    Damjanov I
    Verh Dtsch Ges Pathol; 2004; 88():39-44. PubMed ID: 16892532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oncofetal and developmental perspective on testicular germ cell cancer.
    Rijlaarsdam MA; Looijenga LH
    Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotency of spermatogonial stem cells from adult mouse testis.
    Guan K; Nayernia K; Maier LS; Wagner S; Dressel R; Lee JH; Nolte J; Wolf F; Li M; Engel W; Hasenfuss G
    Nature; 2006 Apr; 440(7088):1199-203. PubMed ID: 16565704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice.
    Noguchi T; Noguchi M
    J Natl Cancer Inst; 1985 Aug; 75(2):385-92. PubMed ID: 3860691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant nucleostemin expression supports the undifferentiated properties of germ cell tumors.
    Uema N; Ooshio T; Harada K; Naito M; Naka K; Hoshii T; Tadokoro Y; Ohta K; Ali MA; Katano M; Soga T; Nakanuma Y; Okuda A; Hirao A
    Am J Pathol; 2013 Aug; 183(2):592-603. PubMed ID: 23885716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of pluripotent stem cells.
    Gokhale PJ; Andrews PW
    Curr Opin Genet Dev; 2012 Oct; 22(5):403-8. PubMed ID: 22868175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.
    Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N
    Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.
    Krentz AD; Murphy MW; Zhang T; Sarver AL; Jain S; Griswold MD; Bardwell VJ; Zarkower D
    Dev Biol; 2013 May; 377(1):67-78. PubMed ID: 23473982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of male germ cell cycle arrest and differentiation by DND1 is modulated by genetic background.
    Cook MS; Munger SC; Nadeau JH; Capel B
    Development; 2011 Jan; 138(1):23-32. PubMed ID: 21115610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The teratoma assay: an in vivo assessment of pluripotency.
    Wesselschmidt RL
    Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Embryonal germ cells and germ cell tumors].
    Biermann K; Heukamp LC; Nettersheim D; Steger K; Zhou H; Franke FE; Guetgemann I; Sonnack V; Brehm R; Berg J; Bastian PJ; Müller SC; Wang-Eckert L; Schorle H; Büttner R
    Verh Dtsch Ges Pathol; 2007; 91():39-48. PubMed ID: 18314594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
    Gordeeva OF; Nikonova TM
    Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The germ cell--the mother of all stem cells.
    Donovan PJ
    Int J Dev Biol; 1998; 42(7):1043-50. PubMed ID: 9853836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.